We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Kits Enable Rapid Labeling of Proteins and Other Macromolecules

By LabMedica International staff writers
Posted on 17 Nov 2014
Print article
Image: Lightning-Link is an innovative technology that enables direct labeling of antibodies, proteins, peptides, or other biomolecules (Photo courtesy of Innova Biosciences).
Image: Lightning-Link is an innovative technology that enables direct labeling of antibodies, proteins, peptides, or other biomolecules (Photo courtesy of Innova Biosciences).
Biotech or other life science researchers who prepare their own bioconjugated proteins, antibodies, or macromolecules will benefit from a new series of rapid labeling kits.

Innova Biosciences (Cambridge, United Kingdom), launched new antibody and protein labeling kits within its Lightning-Link Rapid range. These kits enable researchers to label primary antibodies or other proteins in about 20 minutes.

This range of kits include those for labeling molecules with high sensitivity Atto and Cy dyes as well as a rapid biotin conjugation kit. Boasting a reaction with an exceptionally short incubation time, the biotinylation kit yields conjugates with performance characteristics identical to, or better than, those prepared with laborious multistep conjugation procedures. Furthermore, the method does not require desalting or dialysis steps. Thus, Lightning-Link Rapid technology can be used to label small quantities of material with nearly 100% recovery.

Dr. Nick Gee, CEO of Innova, said: "The launch of the Lightning-Link kits completes the development of our Rapid conjugation range, and follows on from the success of the original kits, which had a much longer reaction time. This latest product introduction underlines Lightning-Link as one of the world’s leading bioconjugation technologies, offering easy-to-use labeling that provides excellent results with minimal hands on time and 100% yield.”

Related Links:

Innova Biosciences


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.